News
A growing number of options—from manufacturer discounts to trusted online pharmacies—can help you access Mounjaro affordably ...
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps ...
Hospital groups are celebrating a federal judge’s initial ruling against pharmaceutical makers who contended a government ...
Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...
U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who ...
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
By Patrick Wingrove and Maggie Fick (Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
17h
Pharmaceutical Technology on MSNEli Lilly strikes $1.3bn gene therapy deal with RznomicsThe deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.
Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results